Analyst Price Target is $0.20
▲ +225.20% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for THC Biomed Intl in the last 3 months. The average price target is $0.20, with a high forecast of $0.20 and a low forecast of $0.20. The average price target represents a 225.20% upside from the last price of $0.06.
Current Consensus is
The current consensus among 1 polled investment analysts is to buy stock in THC Biomed Intl.